06 November 2019
Supported by industry sponsors (includes funding from Bayer women’s health budget), the Menstrual Health Coalition (MHC) is a group of Members of Parliament, patient and advocacy organisation, life sciences companies, leading clinicians, and individuals who discuss and make recommendations around menstrual health policy. The MHC has a dedicated workstream on heavy menstrual bleeding (HMB).
Following a series of one-on-one meetings with key opinion leaders and parliamentarians, the MHC launched a campaign on 15 July 2019 focused on HMB. The event, held at Westminster, explored the current pathway barriers that women may encounter and ongoing budgetary issues. It was hosted by MHC Chair, Paula Sherriff MP, and featured remarks from Professor Lesley Regan, President of the Royal College of Obstetricians and Gynaecologists, Dr Anne Connolly from the Royal College of General Practitioners, and an independent patient.
To ensure that informed decisions can be taken about treatment options, Professor Lesley Regan stated that, “Women should be empowered with choice, but first, women must be made aware of what their choices are.”
To further highlight the need for open discussion between women and clinicians, the MHC has accompanied the campaign with a Twitter hashtag #TalkingPeriods and launched a call for written evidence on HMB.
For more information on the MHC, please visit: https://www.menstrualhealthcoalition.com/ or follow the hashtag #TalkingPeriods